@misc{indiciae590f3309af54,
  title = {Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro},
  author = {Drayman, N. and Jones, K. A. and Azizi, S.-A. and Froggatt, H. M. and Tan, K. and Ivanova Maltseva, N. and Chen, S. and Nicolaescu, V. and Dvorkin, S. and Furlong, K. and Kathayat, R. S. and Firpo, M. R. and Mastrodomenico, V. and Bruce, E. A. and Schmidt, M. M. and Jedrzejczak, R. and Munoz-Alia, M. A. and Schuster, B. and Nair, V. and Botten, J. W. and Brooke, C. B. and Baker, S. C. and Mounce, B. C. and Heaton, N. S. and Dickinson, B. C. and Jaochimiak, A. and Randall, G. and Tay, S.},
  year = {2020},
  doi = {10.1101/2020.08.31.274639},
  url = {https://www.biorxiv.org/content/10.1101/2020.08.31.274639v1},
  note = {Source identifier: 10.1101/2020.08.31.274639}
}